| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Serina Therapeutics, Inc. | Chief Financial Officer | Stock Option (right to buy) | 250,000 | 15 Aug 2024 | Direct | ||
| Angion Biomedica Corp. | Chief Financial Officer | Stock Option (Right to Buy) | 100,000 | 02 Mar 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SER | Serina Therapeutics, Inc. | 15 Aug 2024 | 1 | $0 | 4 | Chief Financial Officer | 20 Aug 2024, 21:01 |
| SER | Serina Therapeutics, Inc. | 15 Aug 2024 | 0 | $0 | 3 | Chief Financial Officer | 20 Aug 2024, 20:59 |
| ELTX | Angion Biomedica Corp. | 02 Mar 2022 | 1 | $0 | 4 | Chief Financial Officer | 04 Mar 2022, 15:20 |
| ELTX | Angion Biomedica Corp. | 15 Dec 2021 | 1 | +$9,480 | 4 | Interim Chief Financial Officer | 16 Dec 2021, 15:58 |